Vaishali Pharma (NSE:VAISHALI) ROCE % : 26.63% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Vaishali Pharma ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vaishali Pharma's annualized ROCE % for the quarter that ended in Dec. 2023 was 26.63%.

Vaishali Pharma ROCE % Historical Data

The historical data trend for Vaishali Pharma's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaishali Pharma ROCE % Chart

Vaishali Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

15.26

10.12

15.31

29.06

29.02

Vaishali Pharma Quarterly Data
	Sep18	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															47.11	12.02	21.78	22.86	26.63

Vaishali Pharma ROCE % Calculation

Vaishali Pharma's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	111.026	/	( ( (816.24 - 519.369)	+	(788.98 - 320.678) )	/ 2 )
	=	111.026	/	( (296.871	+	468.302)	/ 2 )
	=	111.026	/	382.5865
	=	29.02 %

Vaishali Pharma's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	131.932	/	( ( (801.666 - 306.195)	+	(0 - 0) )	/ 1 )
	=	131.932	/	( ( 495.471	+	0 )	/ 1 )
	=	131.932	/	495.471
	=	26.63 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Vaishali Pharma (NSE:VAISHALI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vaishali Pharma ROCE % Related Terms

Thank you for viewing the detailed overview of Vaishali Pharma's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaishali Pharma (NSE:VAISHALI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vaishali Pharma Ltd (NSE:VAISHALI) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

R.C. Patel Road, Off Sodawala Lane, 706-709, 7th Floor, Aravalli Business Center, Borivili (West), Mumbai, MH, IND, 400092

Website

http://www.vaishalipharma.com

Vaishali Pharma Ltd is a pharmaceutical company. The company is engaged in the business of trading (including exports) pharmaceuticals products. It mainly deals in Active Pharmaceutical Ingredient, pharmaceutical formulations, surgical products, Herbal and Nutraceutical Products, and veterinary supplements operating in the domestic and export market.

Vaishali Pharma (NSE:VAISHALI) Headlines

No Headlines